CID 16719221

Avutometinib

Structural Information

Molecular Formula
C21H18FN5O5S
SMILES
CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F
InChI
InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27)
InChIKey
LMMJFBMMJUMSJS-UHFFFAOYSA-N
Compound name
3-[[3-fluoro-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

27
References

1335
Patents

471.10126 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 472.10854 210.6
[M+Na]+ 494.09048 220.5
[M-H]- 470.09398 217.5
[M+NH4]+ 489.13508 213.7
[M+K]+ 510.06442 214.9
[M+H-H2O]+ 454.09852 198.0
[M+HCOO]- 516.09946 224.2
[M+CH3COO]- 530.11511 238.0
[M+Na-2H]- 492.07593 216.8
[M]+ 471.10071 216.3
[M]- 471.10181 216.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe